These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36198077)

  • 21. Effects of left bundle branch block on echocardiographic coronary flow assessment: A systematic review.
    Donelli D; Antonelli M; Gurgoglione FL; Lazzeroni D; Niccoli G; Cortigiani L; Gaibazzi N
    Echocardiography; 2024 Jun; 41(6):e15864. PubMed ID: 38889092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Sex Difference of Coronary Microvascular Dysfunction on Long-Term Outcomes in Deferred Lesions.
    Chung JH; Lee KE; Lee JM; Her AY; Kim CH; Choi KH; Song YB; Hahn JY; Kim HY; Choi JH; Garg S; Doh JH; Nam CW; Koo BK; Shin ES
    JACC Cardiovasc Interv; 2020 Jul; 13(14):1669-1679. PubMed ID: 32593698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of hyperemic response during fractional flow reserve measurement to coronary flow reserve.
    Yamazaki T; Saito Y; Kobayashi T; Kitahara H; Kobayashi Y
    J Cardiol; 2022 Dec; 80(6):532-536. PubMed ID: 35882611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of impaired coronary microcirculation to increased urine albumin excretion in patients with systemic hypertension and no epicardial coronary arterial narrowing.
    Tsiachris D; Tsioufis C; Dimitriadis K; Syrseloudis D; Rousos D; Kasiakogias A; Papademetriou V; Tousoulis D; Stefanadis C
    Am J Cardiol; 2012 Apr; 109(7):1026-30. PubMed ID: 22221953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The waveform index of the ophthalmic artery predicts impaired coronary flow reserve.
    Kojima S; Maruyoshi H; Kojima S; Ogawa H
    Microvasc Res; 2016 May; 105():30-3. PubMed ID: 26723538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Implications of Resistive Reserve Ratio in Patients With Coronary Artery Disease.
    Lee SH; Lee JM; Park J; Choi KH; Hwang D; Doh JH; Nam CW; Shin ES; Hoshino M; Murai T; Yonetsu T; Mejía-Rentería H; Kakuta T; Escaned J;
    J Am Heart Assoc; 2020 Apr; 9(8):e015846. PubMed ID: 32306809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease.
    Tona F; Serra R; Di Ascenzo L; Osto E; Scarda A; Fabris R; Montisci R; Famoso G; Tellatin S; Foletto M; Giovagnoni A; Iliceto S; Vettor R
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):447-53. PubMed ID: 24548662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractional Flow Reserve or Coronary Flow Reserve for the Assessment of Myocardial Perfusion : Implications of FFR as an Imperfect Reference Standard for Myocardial Ischemia.
    Stegehuis VE; Wijntjens GW; Piek JJ; van de Hoef TP
    Curr Cardiol Rep; 2018 Jul; 20(9):77. PubMed ID: 30046914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.
    Bajaj NS; Singh A; Zhou W; Gupta A; Fujikura K; Byrne C; Harms HJ; Osborne MT; Bravo P; Andrikopolou E; Divakaran S; Bibbo CF; Hainer J; Skali H; Taqueti V; Steigner M; Dorbala S; Charytan DM; Prabhu SD; Blankstein R; Deo RC; Solomon SD; Di Carli MF
    Circulation; 2020 Jan; 141(1):21-33. PubMed ID: 31779467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    Suppogu N; Wei J; Nelson MD; Cook-Wiens G; Cheng S; Shufelt CL; Thomson LEJ; Tamarappoo B; Berman DS; Samuels B; Azarbal B; Anderson RD; Petersen JW; Handberg EM; Pepine CJ; Merz CNB
    Int J Cardiol; 2020 Jun; 309():19-22. PubMed ID: 32037132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk Stratification of Patients With NonObstructive Coronary Artery Disease Using Resistive Reserve Ratio.
    Toya T; Ahmad A; Corban MT; Ӧzcan I; Sara JD; Sebaali F; Escaned J; Lerman LO; Lerman A
    J Am Heart Assoc; 2021 Jun; 10(11):e020464. PubMed ID: 33998253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary flow reserve and relative flow reserve measured by N-13 ammonia PET for characterization of coronary artery disease.
    Cho SG; Park KS; Kim J; Kang SR; Song HC; Kim JH; Cho JY; Hong YJ; Jabin Z; Park HJ; Jeong GC; Kwon SY; Paeng JC; Kim HS; Min JJ; Garcia EV; Bom HH
    Ann Nucl Med; 2017 Feb; 31(2):144-152. PubMed ID: 27848160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease: A systematic review and meta-analysis.
    Brainin P; Frestad D; Prescott E
    Int J Cardiol; 2018 Mar; 254():1-9. PubMed ID: 29407076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired coronary flow reserve in patients with indeterminate form of Chagas' disease.
    Rabelo DR; Rocha MO; de Barros MV; Silva JL; Tan TC; Nunes MC
    Echocardiography; 2014; 31(1):67-73. PubMed ID: 24103102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the presence of AA amyloidosis associated with impaired coronary flow reserve?
    Bulut M; Keles N; Caliskan Z; Kostek O; Aksu F; Ozdil K; Akcakoyun M; Demircioglu K; Yilmaz Y; Kanbay M; Caliskan M
    Atherosclerosis; 2016 Aug; 251():389-395. PubMed ID: 27282832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.
    Murthy VL; Naya M; Foster CR; Hainer J; Gaber M; Dorbala S; Charytan DM; Blankstein R; Di Carli MF
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1025-34. PubMed ID: 23058070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary flow reserve during dipyridamole stress echocardiography predicts mortality.
    Cortigiani L; Rigo F; Gherardi S; Bovenzi F; Molinaro S; Picano E; Sicari R
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1079-85. PubMed ID: 23153906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.
    Taqueti VR; Hachamovitch R; Murthy VL; Naya M; Foster CR; Hainer J; Dorbala S; Blankstein R; Di Carli MF
    Circulation; 2015 Jan; 131(1):19-27. PubMed ID: 25400060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.
    Kelshiker MA; Seligman H; Howard JP; Rahman H; Foley M; Nowbar AN; Rajkumar CA; Shun-Shin MJ; Ahmad Y; Sen S; Al-Lamee R; Petraco R;
    Eur Heart J; 2022 Apr; 43(16):1582-1593. PubMed ID: 34849697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation between epicardial adipose tissue and coronary flow reserve in coronary heart disease patients with no chest pain].
    Zhang M; Li ZP; Li WH; Li D; Liu LN; Feng XH; Gao W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Dec; 46(6):848-53. PubMed ID: 25512270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.